| NCT ID | NCT07764172 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) |
| Condition | Sarcopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-08 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-08 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this observational study is to determine the prevalence of sarcopenia in patients aged 50 years and older with acute ischemic stroke, to characterize its trajectory during the acute phase using instrumental verification and functional-cognitive assessments, and to evaluate its impact on functional outcome at three months. The main research question is: Is the presence of sarcopenia at admission associated with less favorable stroke outcomes, including higher rates of complications and mortality? Participants receiving standard medical care for acute ischemic stroke will undergo extended functional assessment for sarcopenia, and a subset will additionally undergo cognitive evaluation.
Eligibility Criteria
Inclusion Criteria: * Age 50 years and older * Acute ischemic stroke confirmed by CT or MRI * Admission within the first 72 hours * Written informed consent and availability of a contact telephone number for follow-up Exclusion Criteria: * TIA without a visible lesion on neuroimaging; bilateral hemiparesis * Amputations or severe contractures that preclude anthropometric assessment * Active cancer at stage IV or life expectancy of less than 3 months * Neuromuscular diseases; chronic use of systemic glucocorticoids for more than 3 months * Pregnancy; refusal to participate Discontinuation criteria (drop-out) * Discharge or death within the first 7 days * Withdrawal of consent * Transfer to another facility resulting in loss of contact
Frequently Asked Questions
Who can join the NCT07764172 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07764172 currently recruiting?
Yes, NCT07764172 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) to inquire about joining.
Where is the NCT07764172 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT07764172 clinical trial?
NCT07764172 is sponsored by University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba). The trial plans to enroll 400 participants.